Terms: = Kidney tumors AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2
95 results:
1. Pazopanib stimulates senescence of renal carcinoma cells through targeting nuclear factor E2-related factor 2 (nrf2).
Wang X; Yang J; Li D; Teng L; Chen Y; Meng J; Yang C; Yin Z; Li C
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23689. PubMed ID: 38613465
[TBL] [Abstract] [Full Text] [Related]
2. Ginsenoside Rh4 Facilitates the Sensitivity of Renal Cell Carcinoma to Ferroptosis via the nrf2 Pathway.
Zhao H; Ding R; Han J
Arch Esp Urol; 2024 Mar; 77(2):119-128. PubMed ID: 38583003
[TBL] [Abstract] [Full Text] [Related]
3. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
[TBL] [Abstract] [Full Text] [Related]
4. Computational analysis of protein-protein interactions of cancer drivers in renal cell carcinoma.
Pei J; Zhang J; Cong Q
FEBS Open Bio; 2024 Jan; 14(1):112-126. PubMed ID: 37964489
[TBL] [Abstract] [Full Text] [Related]
5. A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-nrf2-induced renal tumor growth through increased oxidative stress.
Rawat L; Balan M; Sasamoto Y; Sabarwal A; Pal S
Redox Biol; 2023 Dec; 68():102945. PubMed ID: 37898101
[TBL] [Abstract] [Full Text] [Related]
6. DPP9 Stabilizes nrf2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma.
Chang K; Chen Y; Zhang X; Zhang W; Xu N; Zeng B; Wang Y; Feng T; Dai B; Xu F; Ye D; Wang C
Cancer Res; 2023 Dec; 83(23):3940-3955. PubMed ID: 37713596
[TBL] [Abstract] [Full Text] [Related]
7.
Radic Savic Z; Coric V; Vidovic S; Vidovic V; Becarevic J; Milovac I; Reljic Z; Mirjanic-Azaric B; Skrbic R; Gajanin R; Matic M; Simic T
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629712
[TBL] [Abstract] [Full Text] [Related]
8. Necroptosis inhibits autophagy by regulating the formation of RIP3/p62/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer.
Liu X; Liu L; Wang X; Jin Y; Wang S; Xie Q; Jin Y; Zhang M; Liu Y; Li J; Wang Z; Fu X; Jin CY
Phytomedicine; 2023 Sep; 118():154943. PubMed ID: 37421765
[TBL] [Abstract] [Full Text] [Related]
9. FOXA2 controls the anti-oxidant response in FH-deficient cells.
Rogerson C; Sciacovelli M; Maddalena LA; Pouikli A; Segarra-Mondejar M; Valcarcel-Jimenez L; Schmidt C; Yang M; Ivanova E; Kent J; Mora A; Cheeseman D; Carroll JS; Kelsey G; Frezza C
Cell Rep; 2023 Jul; 42(7):112751. PubMed ID: 37405921
[TBL] [Abstract] [Full Text] [Related]
10. SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.
Vokshi BH; Davidson G; Tawanaie Pour Sedehi N; Helleux A; Rippinger M; Haller AR; Gantzer J; Thouvenin J; Baltzinger P; Bouarich R; Manriquez V; Zaidi S; Rao P; Msaouel P; Su X; Lang H; Tricard T; Lindner V; Surdez D; Kurtz JE; Bourdeaut F; Tannir NM; Davidson I; Malouf GG
Nat Commun; 2023 May; 14(1):3034. PubMed ID: 37236926
[TBL] [Abstract] [Full Text] [Related]
11. Association of nanoparticles and nrf2 with various oxidative stress-mediated diseases.
Thiruvengadam R; Venkidasamy B; Samynathan R; Govindasamy R; Thiruvengadam M; Kim JH
Chem Biol Interact; 2023 Aug; 380():110535. PubMed ID: 37187268
[TBL] [Abstract] [Full Text] [Related]
12. The deubiquitylating enzyme USP35 restricts regulated cell death to promote survival of renal clear cell carcinoma.
Wang S; Wang T; Zhang X; Cheng S; Chen C; Yang G; Wang F; Wang R; Zhang Q; Yang D; Zhang Y; Liu S; Qin H; Liu Q; Liu H
Cell Death Differ; 2023 Jul; 30(7):1757-1770. PubMed ID: 37173391
[TBL] [Abstract] [Full Text] [Related]
13. Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort.
Stoltze UK; Hildonen M; Hansen TVO; Foss-Skiftesvik J; Byrjalsen A; Lundsgaard M; Pignata L; Grønskov K; Tumer Z; Schmiegelow K; Brok JS; Wadt KAW
J Med Genet; 2023 Sep; 60(9):842-849. PubMed ID: 37019617
[TBL] [Abstract] [Full Text] [Related]
14. FXR1 facilitates axitinib resistance in clear cell renal cell carcinoma via regulating KEAP1/nrf2 signaling pathway.
Huang H; Zhang J; Jiang P; Xu X; Huang F; Zhao B; Wang X; Zhou L
Anticancer Drugs; 2023 Feb; 34(2):248-256. PubMed ID: 36730618
[TBL] [Abstract] [Full Text] [Related]
15. Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy.
Rustum YM; Reis R; Rustum TM
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674417
[TBL] [Abstract] [Full Text] [Related]
16. YAP-Activated SATB2 Is a Coactivator of nrf2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma.
Jin J; Chen F; He W; Zhao L; Lin B; Zheng D; Chen L; He H; He Q
Cancer Res; 2023 Mar; 83(5):786-803. PubMed ID: 36598364
[TBL] [Abstract] [Full Text] [Related]
17. 5-Hydroxyeicosatetraenoic Acid Controls Androgen Reduction in Diverse Types of Human Epithelial Cells.
Hardaway AL; Goudarzi M; Berk M; Chung YM; Zhang R; Li J; Klein E; Sharifi N
Endocrinology; 2022 Nov; 164(1):. PubMed ID: 36412122
[TBL] [Abstract] [Full Text] [Related]
18. Assessment of cancer-related signaling pathways in responses to polystyrene nanoplastics via a kidney-testis microfluidic platform (KTP).
Xiao M; Li X; Zhang X; Duan X; Lin H; Liu S; Sui G
Sci Total Environ; 2023 Jan; 857(Pt 1):159306. PubMed ID: 36216064
[TBL] [Abstract] [Full Text] [Related]
19. Development of l-Dopa-containing diketopiperazines as blood-brain barrier shuttle.
Cornacchia C; Marinelli L; Di Rienzo A; Dimmito MP; Serra F; Di Biase G; De Filippis B; Turkez H; Mardinoglu A; Bellezza I; Di Stefano A; Cacciatore I
Eur J Med Chem; 2022 Dec; 243():114746. PubMed ID: 36099749
[TBL] [Abstract] [Full Text] [Related]
20. Silibinin ameliorates cisplatin-induced acute kidney injury via activating Nfe2l1-mediated antioxidative response to suppress the ROS/MAPK signaling pathway.
Yang F; Jia M; Deng C; Xiao B; Dai R; Xiang Y
J Mol Histol; 2022 Aug; 53(4):729-740. PubMed ID: 35727472
[TBL] [Abstract] [Full Text] [Related]
[Next]
